Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) FCF Margin (2019 - 2025)

Biodesix (BDSX) has disclosed FCF Margin for 7 consecutive years, with 2.41% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 2656.0% year-over-year to 2.41%, compared with a TTM value of 26.59% through Dec 2025, up 4615.0%, and an annual FY2025 reading of 26.59%, up 4615.0% over the prior year.
  • FCF Margin was 2.41% for Q4 2025 at Biodesix, up from 41.01% in the prior quarter.
  • Across five years, FCF Margin topped out at 6.81% in Q2 2021 and bottomed at 204.05% in Q1 2022.
  • Average FCF Margin over 5 years is 83.54%, with a median of 81.19% recorded in 2022.
  • The sharpest move saw FCF Margin soared 11148bps in 2021, then tumbled -16320bps in 2022.
  • Year by year, FCF Margin stood at 148.49% in 2021, then increased by 3bps to 144.46% in 2022, then grew by 28bps to 104.08% in 2023, then soared by 77bps to 24.16% in 2024, then soared by 110bps to 2.41% in 2025.
  • Business Quant data shows FCF Margin for BDSX at 2.41% in Q4 2025, 41.01% in Q3 2025, and 33.07% in Q2 2025.